Newsfeed

This area is a possible form of presentation for the integration of news sources relating to listed companies.
The presentation level is a template based on short news services, where users can get a quick overview of the latest news. The detailed views enable further research if interested.

This newsfeed is a compilation of current news from direct connections of TopTier NewsWire services related to listed companies. This feed is for demonstration purposes only. Sector-specific news, public relations and product information can be accessed via the GICS portals > Sector Intelligence section.

US0327973006
Reset filter
Do you already know our new terminal view? Click here.
FIGI: BBG000C9K8K4
AVXL
Anavex Life Sciences Corp
GICS: Health Care · SECTOR: EQTY · SUB-SECTOR: Biotechnology · THEMEFOLIO: $HLTH
NAME
Anavex Life Sciences Corp
ISIN
US0327973006
TICKER
AVXL
MIC
XNAS
REUTERS
AVXL.OQ
BLOOMBERG
AVXL US
Tue, 03.11.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - November 3, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period"), of the important November 30, 2026 lead plaintiff deadline in t...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Tue, 03.11.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - November 3, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Anavex Life Sciences Corp. (NASDAQ: AVXL) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged vi...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Tue, 03.11.2026       Anavex Life Sciences
US0327973006

Seasoned biopharmaceutical executive with more than 30 years of leadership experience spanning clinical development, regulatory strategy and operational execution appointed to lead company into new phase of clinical development and growth Seasoned biopharmaceutical executive with more than 30 years of leadership experience spanning clinical develop...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Mon, 02.11.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - November 2, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period"), of the important November 30, 2026 lead plaintiff deadline in t...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Mon, 02.11.2026       Anavex Life Sciences
US0327973006

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Anavex To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Anavex between November 26, 2025 and August 28, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Sun, 01.11.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - November 1, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period"), of the important November 30, 2026 lead plaintiff deadline in t...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Sat, 31.10.2026       Anavex Life Sciences
US0327973006

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Anavex To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Anavex between November 26, 2025 and August 28, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Sat, 31.10.2026       Anavex Life Sciences
US0327973006

NEW YORK, Oct. 31, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period"), of the important Nov...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Sat, 31.10.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - October 30, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period"), of the important November 30, 2026 lead plaintiff deadline in t...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Fri, 30.10.2026       Anavex Life Sciences
US0327973006

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Anavex To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Anavex between November 26, 2025 and August 28, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Fri, 30.10.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - October 30, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ: AVXL) on behalf of investors that purchased or otherwise acquired Anavex securities between November 26, 2025 and August 28, 2026 (the...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Fri, 30.10.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - October 29, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period"), of the important November 30, 2026 lead plaintiff deadline in t...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Thu, 29.10.2026       Anavex Life Sciences
US0327973006

NEW YORK, Oct. 29, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ: AVXL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Thu, 29.10.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - October 28, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period"), of the important November 30, 2026 lead plaintiff deadline in t...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Wed, 28.10.2026       Anavex Life Sciences
US0327973006

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Anavex To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Anavex between November 26, 2025 and August 28, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Wed, 28.10.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - October 28, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Anavex Life Sciences Corp. (NASDAQ: AVXL) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged vi...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Wed, 28.10.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - October 28, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ: AVXL) on behalf of investors that purchased or otherwise acquired Anavex securities between November 26, 2025 and August 28, 2026 (the...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Wed, 28.10.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - October 27, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period"), of the important November 30, 2026 lead plaintiff deadline in t...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Tue, 27.10.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - October 26, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period"), of the important November 30, 2026 lead plaintiff deadline in t...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Mon, 26.10.2026       Anavex Life Sciences
US0327973006

Complaint alleges Anavex Life Sciences Corp. misled investors between November 26, 2025 and August 28, 2026; investors may seek lead plaintiff role by November 30, 2026LOS ANGELES, Oct. 26, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP ("Glancy") announced today that the class action lawsuit covers investors who bought Anavex Life Sci...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Mon, 26.10.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - October 26, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ: AVXL) on behalf of investors that purchased or otherwise acquired Anavex securities between November 26, 2025 and August 28, 2026 (the...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Mon, 26.10.2026       Anavex Life Sciences
US0327973006

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Anavex To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Anavex between November 26, 2025 and August 28, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Mon, 26.10.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - October 25, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period"), of the important November 30, 2026 lead plaintiff deadline in the se...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Sat, 24.10.2026       Anavex Life Sciences
US0327973006

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Anavex To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Anavex between November 26, 2025 and August 28, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Sat, 24.10.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - October 23, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period"), of the important November 30, 2026 lead plaintiff deadline in the se...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Fri, 23.10.2026       Anavex Life Sciences
US0327973006

Suit alleges Anavex Life Sciences Corp. failed to disclose key facts to investors from November 26, 2025 through August 28, 2026; lead plaintiff deadline is November 30, 2026BENSALEM TOWNSHIP, Pa., Oct. 23, 2026 /PRNewswire/ -- The Law Offices of Howard G. Smith today reported that a securities class action lawsuit is pending against Anavex Life S...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Fri, 23.10.2026       Anavex Life Sciences
US0327973006

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Anavex To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Anavex between November 26, 2025 and August 28, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Fri, 23.10.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - October 23, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ: AVXL) on behalf of investors that purchased or otherwise acquired Anavex securities between November 26, 2025 and August 28, 2026 (the...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Fri, 23.10.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - October 22, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period"), of the important November 30, 2026 lead plaintiff deadline in t...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Thu, 22.10.2026       Anavex Life Sciences
US0327973006

Lawsuit alleges Anavex Life Sciences Corp. made misleading statements to investors from November 26, 2025 to August 28, 2026; lead plaintiff motions are due November 30, 2026LOS ANGELES, Oct. 22, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz today announced a class action lawsuit against Anavex Life Sciences Corp. ("Anavex" or the "Company...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Thu, 22.10.2026       Anavex Life Sciences
US0327973006

Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of persons and entities who purchased or otherwise acquired Anavex Life Sciences Corp. (NASDAQ: AVXL) securities between November 26, 2025 and August 28, 2026, inclusive (the "Class Period"). Anavex describes itself as "a publicly traded biopharmaceuti...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Thu, 22.10.2026       Anavex Life Sciences
US0327973006

NEW YORK, Oct. 22, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ: AVXL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Wed, 21.10.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - October 21, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period"), of the important November 30, 2026 lead plaintiff deadline in t...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Wed, 21.10.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - October 21, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Anavex Life Sciences Corp. (NASDAQ: AVXL) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged vi...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Wed, 21.10.2026       Anavex Life Sciences
US0327973006

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Anavex To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Anavex between November 26, 2025 and August 28, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Wed, 21.10.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - October 21, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ: AVXL) on behalf of investors that purchased or otherwise acquired Anavex securities between November 26, 2025 and August 28, 2026 (the...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Tue, 20.10.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - October 20, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period"), of the important November 30, 2026 lead plaintiff deadline in t...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Tue, 20.10.2026       Anavex Life Sciences
US0327973006

NEW YORK, Oct. 20, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period"), of the important Nov...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Tue, 20.10.2026       Anavex Life Sciences
US0327973006

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Anavex To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Anavex between November 26, 2025 and August 28, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Mon, 19.10.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - October 19, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period"), of the important November 30, 2026 lead plaintiff deadline in t...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Mon, 19.10.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - October 19, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ: AVXL) on behalf of investors that purchased or otherwise acquired Anavex securities between November 26, 2025 and August 28, 2026 (the...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Sun, 18.10.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - October 18, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period"), of the important November 30, 2026 lead plaintiff deadline in the se...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Sat, 17.10.2026       Anavex Life Sciences
US0327973006

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Anavex To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Anavex between November 26, 2025 and August 28, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Sat, 17.10.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - October 16, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period"), of the important November 30, 2026 lead plaintiff deadline in the se...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Fri, 16.10.2026       Anavex Life Sciences
US0327973006

San Diego, California--(Newsfile Corp. - October 16, 2026) - Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of persons and entities who purchased or otherwise acquired Anavex Life Sciences Corp. (NASDAQ: AVXL) securities between November 26, 2025 and August 28, 2026, inclusive (the "Class Period")....
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Fri, 16.10.2026       Anavex Life Sciences
US0327973006

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Anavex To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Anavex between November 26, 2025 and August 28, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Fri, 16.10.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - October 16, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ: AVXL) on behalf of investors that purchased or otherwise acquired Anavex securities between November 26, 2025 and August 28, 2026 (the...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Fri, 16.10.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - October 15, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period"), of the important November 30, 2026 lead plaintiff deadline in t...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Thu, 15.10.2026       Anavex Life Sciences
US0327973006

NEW YORK, Oct. 15, 2026 /PRNewswire/ --Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period"), of the important November 30, 2026 lead plaintiff deadline in the securities class acti...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink
Thu, 15.10.2026       Anavex Life Sciences
US0327973006

New York, New York--(Newsfile Corp. - October 15, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Anavex Life Sciences Corp. (NASDAQ: AVXL) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged vi...
Read more
Anavex Life Sciences
Technical Analysis Termsheets Terminal
Permalink